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Aims Through a 4-year follow-up of the abstracts submitted to the European Society of Cardiology Congress in 2006, we
aimed at identifying factors predicting high-quality research, appraising the quality of the peer review and editorial
processes, and thereby revealing potential ways to improve future research, peer review, and editorial work.
Methods
and results
All abstracts submitted in 2006 were assessed for acceptance, presentation format, and average reviewer rating.
Accepted and rejected studies were followed for 4 years. Multivariate regression analyses of a representative selec-
tion of 10% of all abstracts (n ¼ 1002) were performed to identify factors predicting acceptance, subsequent publi-
cation, and citation. A total of 10 020 abstracts were submitted, 3104 (31%) were accepted for poster, and 701 (7%)
for oral presentation. At Congress level, basic research, a patient number ≥ 100, and prospective study design were
identified as independent predictors of acceptance. These factors differed from those predicting full-text publication,
which included academic affiliation. The single parameter predicting frequent citation was study design with rando-
mized controlled trials reaching the highest citation rates. The publication rate of accepted studies was 38%, whereas
only 24% of rejected studies were published. Among published studies, those accepted at the Congress received
higher citation rates than rejected ones.
Conclusions Research of high quality was determined by study design and largely identified at Congress level through blinded peer
review. The scientometric follow-up revealed a marked disparity between predictors of full-text publication and
those predicting citation or acceptance at the Congress.
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Introduction
The Congress of the European Society of Cardiology (ESC) is one
of the largest international scientific meetings worldwide, yearly
attracting approximately 30 000 health care professionals from
more than 60 countries.1,2 Scientific meetings like this provide an
excellent forum for distribution and discussion of the most
recent scientific findings. However, the factors that determine ac-
ceptance at a scientific meeting, and whether these factors also
predict subsequent full-text publication are largely unknown. More-
over, a validation of the parameters that predict acceptance at a sci-
entific meeting or acceptance for full-text publication with respect
to their later impact has not been performed.
Several studies have investigated distinct aspects such as positive
outcome- or institutional bias associated with the acceptance at
scientific meetings or publication in peer review journals.3 –6 Few
studies have assessed the publication fate of abstracts submitted
to scientific meetings.7– 9 In the field of cardiology, Toma et al.10
specifically investigated the fate of randomized controlled trials
(RCTs) presented at the scientific meetings of the American
College of Cardiology between 1999 and 2002. Ross et al. evalu-
ated the effects of blinded peer review for abstracts submitted
to the Scientific Sessions of the American Heart Association
from 2000 to 2004.10,11 To date, no study has followed the
same cohort of abstracts from their submission to a scientific
meeting over their full-text publication up to their subsequent
impact after publication. Without an external and neutral surrogate
for scientific quality such as citation analysis, earlier studies could
not appraise whether the observed effects affected later scientific
impact.
Our objective was to identify distinct factors predicting accept-
ance at an international scientific meeting in the field of cardiology
as well as parameters predicting subsequent full-text publication
and citation. Beyond prediction at each of these levels, we aimed
to validate the parameters predicting acceptance at Congress
level or publication with those parameters predicting subsequent
scientific impact, thereby appraising the quality of the peer
review and editorial processes involved at each stage.
To accomplish these goals, we assessed all 10 020 abstracts sub-
mitted to the Congress of the ESC in 2006 (i.e. joint meeting of the
ESC and the World Heart Foundation) and followed a representa-
tive sample of 10% (n ¼ 1002 abstracts) of both accepted and
rejected abstracts over a period of 4 years for full-text publication
and subsequent 2-year citations as a surrogate for scientific impact.
Methods
Study design and categorization of abstracts
All 10 020 abstracts submitted to the ESC congress in 2006 were
entered into a database and assessed for acceptance, presentation
format (oral vs. poster presentation), and the average reviewer
rating. For a precise assessment and scientometric follow-up, a
computer-assisted random selection of 10% (n ¼ 1002, margin of
error ¼ 0.01)12 of all abstracts submitted was assessed in detail
according to a set of pre-specified variables. These variables were
origin and type (clinical vs. basic) of research, origin and type
(university-affiliated vs. not university-affiliated) of institution, study
design (RCTs vs. prospective non-randomized trials vs. retrospective
studies vs. systematic reviews vs. meta-analyses), the number of
patients enrolled in clinical studies, the study field of clinical research,
and the gender of first and last authors. The reliability of the computer-
assisted representative random selection was confirmed by comparing
the distribution of variables common to both the original sample of all
10 020 abstracts and the randomly selected sample of 1002 abstracts;
these common variables were acceptance at the Congress (accepted
vs. rejected), presentation format, and average reviewer rating. No dif-
ferences were observed (see Supplementary material online, Table S4).
Gender of first and last authors was assessed using a standardized
algorithm based on the analysis of their first and surnames in conjunc-
tion with their country of origin. In specific cases, this approach was
supplemented using online searches for photographs associated with
their home institution when necessary and available. This algorithm
is described in detail in the online supplementary material and was
developed a priori. Given the need to use this empirical approach,
however, the analyses that included gender should be considered
exploratory.
Scientometric follow-up for publication
and citation
The representative random selection of all abstracts submitted (includ-
ing both accepted and rejected abstracts) was followed for the time
point and journal of publication and for the number of subsequent
2-year citations, beginning from the time of publication. Abstracts
were followed for 4 years. The impact factor of the journal of publica-
tion was assessed for the year of publication. To identify whether an
abstract had been published, the following algorithm was used: first,
the full abstract title was entered as search term in PubMedw. If no
publication was identified, a shortened version of the abstract title
(keywords only, no adjectives) was entered. If still no publication
was identified, the full list of authors was entered in PubMedw,
which, in case of no match, was followed by the names of only the
first and last authors. If again no publication was identified, the same
algorithm was repeated first in Google Scholar, then in Google, each
indexing increasing amounts of contents. Thus, articles published in
journals not indexed in Pubmedw were identified. The Cochrane
library was searched for abstracts of systematic reviews. To validate
that identified articles and the respective abstracts matched, the fol-
lowing parameters were compared for every full-text article that
was identified: primary endpoint(s), the number and size of the
study groups, and the conclusions. Articles assessing the same end-
points in the same number of study groups of the same or slightly
increased sizes, leading to the same conclusions, and published by
the same last authors compared with the respective abstract were
considered ‘published’. The number of 2-year citations of original arti-
cles (beginning from the time of publication) was determined using the
citation indexing and search service of the ISI (Institute of Scientific In-
formation) Web of Science (Thomson Reuters).13 Data were collected
by four independent reviewers (S.W., D.A.R., J.H.W., M.H.) in January
and February 2011, and updated in December 2011 for completion of
the follow-up of 2-year citations. In a pilot study, 3% of the study
samples (n ¼ 30) were assessed independently by each of the four
reviewers to address inter observer variances. Thereafter, one out
of the four reviewers assessed each of the 1002 abstracts. The
cut-off for ‘high’ 2-year citation rates was set to 10 or more (≥85th
percentile of all published studies) in order to identify the top 15%
of published articles. Receiver operating characteristic (ROC) curve
analyses were performed to evaluate the predictive value of average
reviewer ratings for frequent 2-year citation.
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Regression analyses
Univariable and multivariable binary logistic regression analyses were
performed to identify factors predicting acceptance at Congress
level, as well as subsequent publication and citation frequency. Multi-
variable regression analyses were run using backward conditional vari-
able exclusion and list-wise case exclusion. The threshold for entry
was 0.05 and for exclusion 0.10.
Statistical analyses
Metric variables were assessed for distribution using the Kolmogorov–
Smirnov test and compared by the Mann–Whitney U, one-way
ANOVA, and Kruskal–Wallis H-tests where appropriate. Significance
levels were adjusted for multiple comparisons using conservative Bon-
ferroni’s correction where indicated. Proportional differences derived
from categorical data were compared using the Fisher exact or x2 tests
where appropriate and presented as odds ratio and 95% confidence
interval. P-values were two-sided and considered statistically significant
for P, 0.05, if not indicated differently (multiple comparisons). Statis-
tical analyses were performed with IBM SPSS Statistics Version 19.
Results
From abstract at the ESC congress
to publication
The 10 020 abstracts submitted to the ESC congress in 2006 from
63 different countries of all five continents gave rise to over 2900
publications and over 32 000 citations (Figures 1 and 2, Supplemen-
tary material online, Table S2). Of all abstracts submitted 90% were
clinical studies and 10% were basic research. Nearly one-fifth of
the research submitted had been performed in institutions not
affiliated to universities (Table 1). Half of the clinical studies submit-
ted were retrospective, 35% were designed prospectively, of which
18% were RCTs (Table 1). In a pilot study encompassing 3% of the
study sample (n ¼ 30), inter-observer agreement was assessed.
Fleiss’ kappa values for categorical variables ranged from 0.853
to 1.0, and intraclass correlation coefficients for continuous vari-
ables from 0.996 to 1.0 (see Supplementary material online,
Table S5).
Peer review and editorial process at the
ESC Congress 2006
All abstracts submitted were reviewed by three to eight independ-
ent reviewers, who allotted scores from 1 to 10 for each abstract.
Editorial decisions were based on average reviewer ratings. Re-
viewer ratings showed a central tendency without being normally
distributed (see Supplementary material online, Figure S1).
Abstracts accepted had received significantly higher scores than
those rejected (P, 0.001). Among accepted studies, those
accepted for oral presentation had been rated significantly better
than those accepted for poster presentation (P, 0.001), indicating
a good coherency of reviewer assessment and editorial decisions.
A cut-off for acceptance was identified at an average reviewer
rating of 6.5 (Figure 3A). The predictive value of expert reviewer
assessment for frequent citation (defined as 10 or more 2-year
citations) was 70% (AUC ¼ 0.694, Figure 3B). The best cut-off
for frequent citation was identified to be an average reviewer
rating of greater than 7 (AUC ¼ 0.660, P, 0.001, Table 2).
Concomitantly, studies accepted at the ESC Congress received sig-
nificantly more 2-year citations than rejected ones (P ¼ 0.004 for
oral presentations, P ¼ 0.008 for poster presentations, Figure 3D).
Factors predicting acceptance at the
ESC Congress
Thirty-eight per cent of all submitted studies were accepted, and
only 7% of all submitted abstracts (i.e. 18.4% of all accepted
abstracts) were accepted for oral presentation (Figure 1).
In univariable analyses, two factors were positively associated
with acceptance at Congress level: study design (P ¼ 0.018) and a
patient number of 100 or more (OR ¼ 1.93, P, 0.001). Within
study design, specifically prospective non-randomized study design
(OR¼ 1.90, P ¼ 0.016) and randomized controlled trial design
(OR 1.56, P ¼ 0.004) were identified. The only factor not favouring
acceptance in univariable analysis was research conducted in the
field of rhythmology (OR ¼ 0.57, P ¼ 0.034) with an acceptance
rate of 33% compared with 46% of other abstracts (Table 1).
When adjusting for all factors assessed, the number of patients
enrolled showed the strongest association with acceptance
(adjusted OR ¼ 2.07, P, 0.001), followed by basic as opposed
to clinical research (adjusted OR ¼ 2.24, P ¼ 0.001) with an ac-
ceptance rate of 44 vs. 37%, and study design (P ¼ 0.023).
Within study design, prospective data collections (i.e. prospective
cohort studies and non-randomized intervention trials) (adjusted
OR ¼ 1.67, P ¼ 0.002) and RCTs (adjusted OR ¼ 1.91, P ¼
0.020) favoured acceptance (Table 1). Interestingly, none of the
aspects assessed was associated with oral or poster presentation
among all accepted abstracts (see Supplementary material online,
Table S1).
Factors predicting full-text publication
Of all accepted studies, 38% were subsequently published, whereas
only 24% of rejected studies were published (P, 0.001). The pub-
lication rate of studies accepted for oral presentation (37%) did not
differ from the publication rate of studies accepted for poster pres-
entation (39%, P ¼ 0.79). However, significantly more of those
studies that had been accepted for oral presentation were subse-
quently published in high impact factor journals (30%, IF ≥ 10)
compared with studies that had been accepted for poster presen-
tation (10%, P ¼ 0.009) or rejected studies (4%, P, 0.001)
(Figure 1).
Univariable analyses revealed a significant advantage for institu-
tions affiliated with universities to publish their research (publica-
tion rate 31%) compared with non-university-affiliated
institutions (publication rate ¼ 22%, Table 3). With a publication
rate of 41%, basic research showed the strongest association
with publication (OR ¼ 1.72, P ¼ 0.012), followed by study
design in clinical research (P ¼ 0.014) and the affiliation to a univer-
sity (OR ¼ 1.53, P ¼ 0.025). Notably, neither prospective nor ran-
domized controlled study design, but meta-analyses contributed to
the significant association of study design with publication in uni-
variable analysis (OR ¼ 5.97, P ¼ 0.041). However, the small
number of meta-analyses in the studied cohort does not allow a
solid statement.
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When adjusting for all factors assessed, prospective non-
randomized study design independently predicted publication
(adjusted OR ¼ 1.44, P ¼ 0.032). Moreover, multivariable analyses
confirmed university affiliation to independently predict publica-
tion (adjusted OR ¼ 1.62, P ¼ 0.018). The number of patients en-
rolled was not associated with full-text publication, while it was
with acceptance at Congress level.
Factors predicting citation
Twenty-one per cent of all studies that had been accepted and sub-
sequently published were cited 10 times or more within the
2 years following publication. In contrast, only 7% of the published
studies that had been rejected were cited 10 times or more in the
2 years following publication (P ¼ 0.008). Citation rates between
published studies that had been accepted for oral presentation
did not differ significantly from those that had been accepted for
poster presentation (P ¼ 0.24). In univariable analyses, the study
field (P ¼ 0.028) and study design (P ¼ 0.001) were associated
with high citation rates (Table 4). After adjusting for the remaining
factors, study design remained the only parameter independently
associated with high citation rates (P ¼ 0.004). In particular,
randomized controlled trial design demonstrated a marked inde-
pendent association with high citation rates (adjusted OR ¼ 6.82,
P, 0.001), followed by prospective non-randomized studies
(adjusted OR ¼ 2.57, P ¼ 0.018). Neither academic affiliation nor
gender of first or last author, nor the number of enrolled patients
influenced citation rates (Table 4).
At Congress level, editorial decisions correlated both with iden-
tified predictors of high citation rates, i.e. study design, and with re-
viewer ratings (Figure 3A). Notably, odds ratios for randomized
controlled trial design differed by over three-fold between the ac-
ceptance at Congress level and high citation rates. Along this line,
there was no significant difference in the number of 2-year cita-
tions between studies accepted for oral and those accepted for
poster presentation (Figure 3D). Over half of the submitted
RCTs were rejected at the ESC congress. However, RCTs still
reached the highest acceptance rate of all factors assessed
(Table 1). Over 80% of the accepted RCTs were accepted for
poster presentation (see Supplementary material online, Table
S1). It is consequently not surprising that a few of the most
highly cited studies evolved from abstracts originally accepted for
poster presentation (Figure 3D).
Figure 1 Fate of studies submitted to the ESC Congress 2006. Overview of submission, acceptance at Congress level, and follow-up for
full-text publication, and citation within 2 years following publication. All abstracts were characterized according to a set of pre-specified para-
meters. Association of these factors with the acceptance at Congress level, with full-text publication, and subsequent citation was assessed by
univariable and mutlivariable regression analyses. Percentages refer to the respective preceding level (n). (n* refers to the representative
random selection of 10% (1002) of all abstracts submitted (10 020), Ø published, not published; IF, impact factor).
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Does female gender affect scientific
success?
As noted earlier, these analyses should be considered exploratory
given that information on gender was not directly available but had
to be empirically determined through an examination of first and
last author names. Of all abstracts submitted, 26% were conducted
by female first authors (Table 1). Only 13% of senior authors were
female, suggesting that both female junior and senior scientists are
markedly underrepresented in the cardiovascular research commu-
nity. Acceptance rates at Congress level did not differ between
female and male scientists (Table 1, Supplementary material
online, Table S3). Among junior researchers, publication rates did
not differ markedly between male and female colleagues (30 vs.
27%, OR ¼ 0.88, P ¼ 0.428) (see Supplementary material online,
Table S3). However, the publication rate of female senior scientists
was markedly lower compared with the one of their male cowor-
kers (18 vs. 31%, P ¼ 0.004, Supplementary material online, Table
S3). Concomitantly, female senior authorship was independently
negatively associated with full-text publication in multivariable re-
gression analysis (adjusted OR ¼ 0.52, P ¼ 0.010, Table 3). Scientif-
ic impact, as assessed by 2-year citation rates, did not differ between
genders (see Supplementary material online, Table S3).
Discussion
In this study, we identified independent predictors of acceptance at
the ESC Congress, subsequent full-text publication and later
impact through specific assessment and scientometric follow-up
of a cohort of abstracts representative for over 10 000 abstracts
submitted to an international scientific meeting (Figure 4). Pro-
spective study design determined acceptance at Congress level,
full-text publication, and subsequent impact after publication. Ran-
domized controlled trials attracted almost seven times more
2-year citations than other studies. Citation-based validation of
the factors predicting acceptance at the Congress level or full-text
publication reveal a potential discrimination of female senior
authors at publication level and indicate superiority of blinded
over open peer review.
Identification of scientific quality at an
early stage
Presentation of abstracts at scientific meetings is an important part
of the dissemination of knowledge. However, more than half of the
studies submitted to scientific congresses are never published,14 as
is also the case for the ESC 2006. Identifying high-quality research
based on distinct aspects when grading large numbers of abstracts
is a challenging task for reviewers and editors. Reviewers and
editors at the ESC Congress successfully identified science of sig-
nificant later impact, given that 29.6% of all studies accepted for
oral presentation received 10 or more 2-year citations compared
with only 7.4% of rejected studies. Based on the assessment of
the abstracts alone, we identified prospective study design, and
specifically randomized controlled study design as strong predic-
tors of scientific impact.
Thus, key aspects of scientific quality are identifiable at the early
stage of an abstract, and, even though markedly less pronounced,
are taken into account in the review and editorial process of
one of the largest international medical conferences.
Hurdles to overcome from abstract to
impact
In the process of medical research, different stages are passed from
the formulation of a well-substantiated hypothesis to a clearly
proven and novel answer, and further to the acceptance of the ela-
borated results in the scientific community. The first hurdle to
overcome is publication. Intriguingly, the factors predicting
Figure 2 Origin of research submitted to the ESC Congress 2006. A total of 10 020 abstracts were submitted to the scientific sessions of the
ESC 2006. Based on the assessment of a representative subsample of 10% (n ¼ 1002) submitted studies originated from 63 different countries
of all five continents. About one-third of all studies were submitted from the American continent, 43% from Western Europe, and 14% from
Eastern Europe and Russia. Less than 10% of studies originated from Africa and Asia/Oceania.
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publication differed substantially from those predicting high citation
rates. In essence, the institution where studies were conducted and
the gender of the respective principal investigator predicted publi-
cation—rather than the scientific content of a study. Such discrep-
ancy hinders the flow of relevant findings to the scientific
community and slows clinical advancement. Once published, the
scientific community itself grades the scientific importance by
either spreading the word through citation or not. This second
and final step of appreciation by fellow scientists in the respective
field was observed to depend only and substantially on research
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Table 1 Factors predicting acceptance at the ESC Congress
Parameters No. of abstracts
submitted
[% total (n)]
Acceptance
rate
[% total (n)]
Univariate reg.
OR, 95% CI (P)
Multivatiate reg.
OR, 95% CI (P)
Overall rates 100.0 (1002) 37.5 (376)
Type of research
Clinical 89.7 (899) 36.8 (331) Ref. Ref.
Basic 10.3 (103) 43.7 (45) 1.33, 0.88–2.01 (0.174) 2.24, 1.39–3.59 (0.001)
Type of institution
Not university-affiliated 19.2 (192) 34.9 (67) Ref.
University-affiliated 80.8 (810) 38.1 (309) 1.51, 0.15–1.60 (0.403)
Study design (clinical) (0.018) (0.023)
Restrospective 49.3 (494) 32.4 (160) Ref. Ref.
Prospective non-RCT 28.9 (290) 42.8 (124) 1.90,1.16–2.10 (0.016) 1.67, 1.22–2.29 (0.002)
RCT 6.5 (65) 47.7 (31) 1.56, 1.13–2.21 (0.004) 1.91, 1.11–3.28 (0.020)
Meta-Analysis 0.6 (6) 50.0 (3) 2.90, 0.42–10.46 (0.370) 0.0 (1.000)
Systematic Review 0.2 (2) 0.0 (0) 0.0 (1.000) 0.0 (1.000)
Other 4.2 (42) 31.0 (13) n.a. n.a.
Number of patients (clinical)a
,100 43.4 (435) 30.3 (132) Ref. Ref.
≥100 41.7 (418) 45.7 (191) 1.93, 1.46–2.56 (<0.001) 2.07, 1.54–2.77 (<0.001)
Study field (clinical) (0.373)
Cardiac imaging, computational, acute
cardiac care
10.3 (103) 44.7 (46) Ref.
Rhythmology 12.7 (127) 31.5 (40) 0.57, 0.34–0.96 (0.034)
Heart failure, left ventricular function, valvular
disease, pulmonary circulation
15.2 (152) 36.8 (56) 0.71, 0.44–1.16 (0.173)
Coronary artery disease, ischaemia 13.2 (132) 31.8 (42) 0.61, 0.37–1.01 (0.055)
Interventional cardiology, peripheral
circulation, stroke
9.4 (94) 39.4 (37) 0.79, 0.47–1.36 (0.390)
Exercise, prevention, epidemiology,
pharmacology, nursing
14.6 (146) 36.3 (53) 0.68, 0.41–1.12 (0.130)
Hypertension, myocardial and pericardial
disease, cardiovascular surgery
9.5 (95) 38.9 (37) 0.83, 0.48–1.42 (0.490)
Other 5.0 (50) 40.0 (20) n.a. n.a.
Gender first authorb
Male 72.2 (723) 39.8 (288) Ref. Ref.
Female 26.0 (261) 33.7 (88) 0.77, 0.57–1.03 (0.082) 0.73, 0.54–1.00 (0.051)
Gender last authorc
Male 84.0 (842) 38.2 (322) Ref.
Female 13.1 (131) 38.9 (51) 1.03, 0.71–1.50 (0.88)
OR, odds ratio; CI, confidence interval; RCT, randomized controlled trial; ref., reference variable for odds ratio calculation; n.a., not applicable. Analyses performed on
representative 10% selection (n ¼ 1002), margin of error,0.01. Backward conditional variable exclusion, c-statistic ¼ 0.620.
Bold value indicates statistically significant findings.
aIn 46 clinical studies, no information on the number of patients was provided.
bIn 18 studies, no gender for the first author could be identified.
cIn 29 studies, no gender for the last author could be identified.
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design. Considering that in current evidence-based medicine clinic-
al guidelines are set forth based on the respective level of
evidence,15 which is primarily based on study design,16 this result
is encouraging. Moreover, our findings indicate that judging scien-
tific quality of medical research based on other factors, such as
the number of patients enrolled, the home institution, or the
gender of the performing researchers, may not be justified.
Peer review and editorial decisions
Expert peer review is the gold standard for research evaluation
when it comes to publication in peer review journals or allocation
of resources.17 Given its importance, surprisingly little research has
been performed in this field.18,19 Abstracts submitted to the ESC
Congress 2006 were subjected to (‘double’-) blinded peer
review (neither authors knew reviewers nor vice versa). Up to
eight independent reviewers graded scientific quality on a scale
from 1 to 10, providing the basis for editorial decision. Information
on sound criteria to specifically evaluate when grading scientific
quality is scarce.20 In this study, we assessed putative determinants
of scientific quality, and identified four aspects that were in the
focus of the peer review and editorial process of the ESC Congress
2006. External validation through citation analyses confirmed two
Figure 3 Peer review and editorial process of the ESC Congress 2006. All abstracts submitted were peer-reviewed in a blinded fashion by
three to eight expert reviewers, and graded on a scale from 1 to 10. (A) Reviewer ratings and editorial decisions. Accepted studies had received
significantly higher ratings than rejected studies; studies for oral presentation had been ranked significantly higher than those for poster pre-
sentations. The cut-off for acceptance at 6.5 was calculated using the Yuden’s index (sensitivity 0.97, specificity 0.92). (B) Receiver operating
characteristic (ROC) curve analyses after the scientometric follow-up of a representative subsample of 10% of all abstracts submitted
(n ¼ 1002) revealed a predictive value of average reviewer ratings of 69.4%. (C) Spearman’s correlation of average reviewer ratings with accept-
ance at the Congress, subsequent full-text-publication and citation rates uncovered a significant positive correlation in all three cases. (D) Com-
parison of the numbers of 2-year citations of both accepted and rejected, subsequently published studies. Analyses revealed that rejected and
subsequently published studies were cited significantly less frequently compared with accepted and subsequently published studies; citation
frequencies between different presentation formats did not differ. AUC, area under the curve, significance level (P, 0.017) adjusted for mul-
tiple comparisons using Bonferroni’s correction, interquartile ranges, whiskers indicate minima and maxima.
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out of these four aspects to be markers of scientific impact, indi-
cating effective peer review and editorial work at this stage. More-
over, a clear cut-off for average reviewer ratings with regard to
acceptance or rejection was identified. Along with significantly
higher ratings of abstracts accepted for oral compared with
those accepted for poster presentation, these data underscore a
coherent cooperation of reviewers and editors. Scientometric
follow-up assigned peer reviewer ratings a predictive value of
70% for later scientific impact, further supporting effective peer
review and editorial work at Congress level.
Assessment of the predictive value of the same set of para-
meters for subsequent full-text publication revealed markedly dif-
ferent factors. External validation through citation analyses did not
confirm any of the identified predicting factors to be markers of
scientific impact: surprisingly, randomized controlled trials design
did not predict publication. Moreover, gender and institutional af-
filiation of the senior author were related to whether or not an ab-
stract led to a full-text publication. As neither gender nor
institutional affiliation delineate scientific quality, a potential bias
during single-blinded review cannot be excluded.
Blinded peer review and scientific quality
Most scientific and medical journals use ‘anonymous’ or ‘single-
blinded’ peer review, i.e. the authors do not know the reviewers.
However, only a minority applies ‘blinded’ or ‘double-blinded’ peer
review, where neither authors know reviewers nor vice versa.3 Dif-
ferent kinds of bias are recognized as confounding factors in the
effort to judge the quality of research.4,17,18,21,22 When the American
Heart Association adopted blinded peer review for their Scientific
Sessions, Ross et al.11 demonstrated that blinded peer review at
least partially reduced reviewer bias with regard to prestigious insti-
tutions or author origin. However, it remained unclear whether the
reduction in bias by adopting blinded peer review would affect later
scientific impact. In the present study, separate validation of blinded
peer review at Congress level and presumably largely single-blinded
peer review at publication level suggests substantial enhancement of
scientific quality by decreasing potential bias through blinded peer
review. Given these data and other reports that blinded peer
review does not only reduce bias but improve scientific quality,23 it
can be speculated that blinded peer review merits consideration
on a broader scale.
Cardiovascular science and gender
The number of women in medical training and entry-level academ-
ic positions has substantially increased in recent years, whereas
their representation in advanced and leading academic positions
has remained comparatively low.24– 27 One of the empirically
best proven hypotheses for this disparity is that women would
publish fewer papers and consequently raise less soft money
compared with their male co-workers.26 Among all abstracts
submitted to the ESC Congress 2006, 26% originated from
female first authors, and only 13% from senior female authors.
Hence, women appear to be underrepresented in both the entry
level and advanced academic positions in cardiovascular medicine.
There were no gender differences with regard to abstract ac-
ceptance in blinded peer review, underlining the absence of qualita-
tive differences, as supported by others.25 Interestingly, the rate of
full-text publication of female senior authors was significantly lower
compared with their male colleagues (19.1 vs. 30.8%). Concomi-
tantly, senior female authorship was identified as independent nega-
tive predictor of full-text publication in multivariable regression
analysis. The scientometric follow-up did not reveal any gender
effects, again supporting the absence of qualitative disparities.
Since we did not assess the number of submissions, but only of suc-
cessful full-text publications, we cannot exclude that female senior
authors have submitted their research less frequently for full-text
publication. Female underrepresentation, and the fact that citation
analyses in this study aimed to assess whether or not a published
article was among the top 15% of published articles, limit the inter-
pretation of female scientific performance. However, the discrep-
ancy between blinded peer review at the Congress level and
largely open peer review at the publication level in this regard
may alert the scientific community to shed light on a potential bias.
Of course, all of the above findings should be interpreted cau-
tiously and considered exploratory, given that information on the
gender of first and last authors was not directly available but had
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Table 2 Determination of the best cut-off of the average reviewer rating for frequent citation
Frequency
[n (%submitted)]
Accepted at
congress [n (%
within rating)]
Published
[n (% within
rating)]
≥10 two year
cit. [n (% within
rating)]
P-value
(Fisher’s
exact)
OR (95% CI) AUC
(ROC
analyses)
Av. Rev. Rating. 6 555 (55.4) 375 (67.6) 199 (35.9) 36 (6.5) 0.036 2.347 (1.04–5.27) 0.584
Av. Rev. Rating . 6.5 394 (39.3) 358 (90.9) 146 (37.1) 32 (8.1) 0.002 3.135 (1.53–6.37) 0.634
Av. Rev. Rating. 7 213 (21.3) 210 (98.6) 81 (38.0) 24 (11.3) <0.001 4.021 (2.07–7.80) 0.660
Av. Rev. Rating . 7.5 111 (11.1) 110 (99.1) 47 (42.3) 15 (13.5) 0.001 3.491 (1.69–7.21) 0.609
Av. Rev. Rating. 8 33 (3.3) 32 (97.0) 15 (45.5) 6 (18.2) 0.015 4.193 (1.41–12.44) 0.553
Av. Rev. Rating . 8.5 12 (1.2) 11 (91.7) 5 (41.7) 4 (33.3) 0.002 24.700 (2.69–226.65) 0.543
Av. Rev. Rating. 9 Not given – – – – – –
P-values, odds ratios (OR), confidence intervals (CI) and area under the curve (AUC) values refer to the categorigal variable of ‘≥ 10 two-year citations’. Random 10% selection
(n ¼ 1002), margin of error,0.01.
Bold value indicates statistically most significant finding in conjunction with the largest AUC.
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Table 3 Factors predicting publication
Parameters No. of
studies
published
No. of studies
not published
Publication Rate
(% submitteda)
Univ. reg. OR,
95% CI (P)
Multiv. reg. OR,
95% CI (P)
Type of research
Clinical 251 648 27.9 Ref. Ref.
Basic 42 61 40.8 1.72, 1.13–2.61 (0.012) 2.11, 1.34–3.34 (0.001)
Type of institution
Not university-affiliated 43 149 22.4 Ref. Ref.
University-affiliated 250 560 30.9 1.53, 1.06–2.22 (0.025) 1.62, 1.09–2.43 (0.018)
Study design (clinical) (0.014) (0.279)
Restrospective 124 370 25.1 Ref. Ref.
Prospective non-RCT 90 200 31.0 1.32, 0.96–1.82 (0.090) 1.44, 1.03–2.02 (0.032)
RCT 22 43 33.8 1.53, 0.88–2.65 (0.133) 1.48, 0.84–2.61 (0.181)
Meta-Analysis 4 2 66.7 5.97, 1.08–32.98 (0.041) 0.0 (1.000)
Systematic Review 0 2 0.0 0.0 (1.000) 0.0 (1.000)
Other 11 31 26.2 n.a. n.a.
Number of patients (clin.)b
,100 120 318 27.4 Ref.
≥100 117 298 28.2 1.08, 0.80–1.46 (0.068)
Study field (clinical) (0.228)
Cardiac imaging, computational,
acute cardiac care
32 71 31.1 Ref.
Rhythmology 30 97 23.6 0.71, 0.41–1.25 (0.236)
Heart failure, left ventricular
function, valvular disease,
pulmonary circulation
40 112 26.3 0.86, 0.51–1.47 (0.588)
Coronary artery disease,
ischaemia
39 93 29.5 0.94, 0.55–1.61 (0.821)
Interventional cardiology,
peripheral circulation, stroke
27 67 28.7 0.86, 0.47–1.55 (0.610)
Exercise, prevention,
epidemiology, pharmacology,
nursing
36 110 24.7 0.76, 0.44–1.32 (0.328)
Hypertension, myocardial and
pericardial disease,
cardiovascular surgery
29 66 30.5 1.12, 0.68–2.12 (0.533)
Other 18 32 36.0 n.a. n.a.
Gender first authorc
Male 217 506 30.0 Ref. Ref.
Female 71 190 27.2 0.88, 0.63–1.18 (0.352) 0.94, 0.67–1.32 (0.723)
Gender last authord
Male 259 583 30.8 Ref. Ref.
Female 25 106 19.1 0.54, 0.34–0.85 (0.008) 0.52, 0.32–0.85 (0.010)
OR, odds ratio; CI, confidence interval; RCT, randomized controlled trial; ref., reference variable for odds ratio calculation; n.a., not applicable. Analyses performed on
representative 10% selection (n ¼ 1002), margin of error, 0.01. Backward conditional variable exclusion, c-statistic ¼ 0.757.
Bold value indicates statistically significant findings.
aPercent submitted refers to submissions to the ESC Congress.
bIn 46 clinical studies, no information on the number of patients was provided.
cIn 18 studies, no gender for the first author could be identified.
dIn 29 studies, no gender for the last author could be identified.
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to be determined using a systematic approach. Given that this
approach was applied a priori (i.e. before any of the analyses
were conducted), however, we believe it is unlikely to lead to
any systematic biases and, if anything, misclassification would
result in findings shifted toward no differences. That said, the im-
portance of understanding the role of gender in research is
critical and certainly requires further confirmation with additional
work.
Limitations
In all regression analyses performed in this study, potential con-
founding factors that were not assessed or included in the
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Table 4 Factors predicting high citation rates
Parameters Articles cited 103 or
more in 2 years
[% of published (n/n)]
Univariate reg. OR,
95% CI (P)
Multivatiate reg. OR,
95% CI (P)
Type of research
Clinical 14.3 (36/251) Ref.
Basic 11.9 (5/42) 0.73, 0.27–1.98 (0.537)
Type of institution
Not university-affiliated 7.0 (3/43) Ref.
University-affiliated 15.2 (38/250) 2.63, 0.77–8.90 (0.121)
Study design (clinical) (0.001) (0.004)
Restrospective 6.5 (8/124) Ref. Ref.
Prospective non-RCT 18.9 (17/90) 3.39, 1.457.90 (0.005) 2.57, 1.20–5.68 (0.018)
RCT 40.9 (9/22) 8.77, 2.96–26.02 (<0.001) 6.82, 2.46–21.12 (0.001)
Meta Analysis 50.0 (2/4) 12.67, 1.59–100.80 (0.016) 16.30, 1.20–281.94 (0.044)
Systematic Review — — —
Other 0.0 (0/11) n.a. n.a.
Number of patients (clinical)a
,100 12.5 (15/120) Ref.
≥100 17.9 (21/117) 1.33, 076–2.67 (0.414)
Study field (clinical) (0.028) (0.114)
Cardiac imaging, computational, acute cardiac
care
17.7 (5/32) Ref. Ref.
Rhythmology 13.3 (4/30) 0.64, 0.16–2.53 (0.528) 0.59, 0.14–2.40 (0.475)
Heart failure, left ventricular function, valvular
disease, pulmonary circulation
7.5 (3/40) 0.33, 0.08–1.44 (0.142) 0.29, 0.06–1.31 (0.119)
Coronary artery disease, ischemia 30.8 (12/39) 1.96, 0.66–5.84 (0.229) .79, 0.54–5.37 (0.331)
Interventional cardiology, peripheral circulation,
stroke
25.9 (7/27) 1.86, 0.56–2.49 (0.310) .44, 0.44–5.72 (0.582)
Exercise, prevention, epidemiology,
pharmacology, nursing
56 (2/36) 0.69, 0.19–2.49 (0.567) 0.71, 0.19–2.95 (0.630)
Hypertension, myocardial and peri-cardial
disease, cardiovascular surgery
6.9 (2/29) 0.42, 0.10–1.62 (0.254) 0.39, 0.09–1.90 (0.230)
Other 5.6 (1/18) n.a. n.a.
Gender first authorb
Male 14.3 (31/217) Ref. Ref.
Female 18.3 (13/71) 1.34, 0.66–2.73 (0.423) 0.0 (1.00)
Gender last authorc
Male 16.6 (43/259) Ref.
Female 4.0 (1/25) 0.22, 0.03–1.66 (0.142)
OR, odds ratio; CI, confidence interval; RCT, randomized controlled trial; ref., reference variable for odds ratio calculation, n.a., not applicable. Analyses performed on
representative 10% selection (n ¼ 1002), margin of error,0.01. Backward conditional variable exclusion, c-statistic ¼ 0.570.
Bold value indicates statistically significant findings.
aIn 46 clinical studies, no information on the number of patients was provided.
bIn 18 studies, no gender for the first author could be identified.
cIn 29 studies, no gender for the last author could be identified.
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respective regression analysis cannot be excluded. Therefore,
extrapolations have to be done with care. For example, although
no predictors of oral presentation among accepted studies were
identified, other aspects such as novelty, which was not assessed
in this study, may also play a role. Of note, the presentation
format at the Congress level is also subject to organizational
aspects, including the arrangement of consistent themes for scien-
tific sessions.
Even though citation analysis is a widely accepted and neutral
tool in evaluative bibliometrics to provide quantitative indicators
for scientific performance,17,28–31 we are aware that it may be
subject to bias. An article published in a very renowned journal
or authored by a well-known expert may enhance the number
of its citations compared with a similar article published in a less
renowned journal or authored by a less known scientist. Citation
analysis can, of course, not replace but only complement expert
peer review in the evaluation of research. However, in the
context of this study, we consider citation suitable as an external
quality assessment in the evaluation of a large number of abstracts.
Due to the extensive amount of studies, all authored by multiple
investigators, self-citation was not assessed. Importantly, no signifi-
cant association between institutional affiliation and the number of
citations of a published article was observed, indicating that this
shortcoming is of minor importance for the respective results.
The chosen publication and citation windows, i.e. 2 years each,
may not cover all full-text publications among the studies assessed.
For the rapid field of biomedical research, however, a publication
and citation window of 2 years each has been described to
cover the majority of publications and citation peaks.9,17,30,31 Fur-
thermore, the assessment of the peer review and editorial
process at publication level is based on the assumption that
studies that were not published in the 4 years following the Con-
gress had been submitted for full-text publication and been
rejected—which was not specifically assessed in this study. In
essence, authors of those studies identified as not published
were not contacted to verify that the respective studies had
been submitted for publication in a peer review journal. Therefore,
the results of the logistic regression analysis on the level of publi-
cation may be affected by factors that led to non-submission as
opposed to reviewer ratings and editorial decisions. Consequently,
Figure 4 Key findings: predictors of acceptance at Congress level, full-text publication, and frequent citation, and their validation with regard
to scientific impact. We identified parameters predicting acceptance, subsequent full-text publication, and high citation rates (≥10 two-year
citations). Parameters predicting scientific impact (+), no association with scientific impact (2). All findings, odds ratios, and confidence inter-
vals (CI) refer to multivariable regression analyses based on a random 10% selection of all abstracts submitted to the ESC Congress 2006
(n ¼ 1002), margin of error, 0.01.
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extrapolations regarding peer review and editorial process at pub-
lication level have to be interpreted with care.
The discussed potential effect of anonymized peer review at
publication level is based on the work of others, stating that less
than 20% of almost all English language scientific and medical jour-
nals use double-blinded peer review.3 Editorial offices of all re-
spective journals in this study sample have not been contacted.
As noted above, author gender was assessed using an algorithm
based on first- and surnames in addition to photographs where ne-
cessary and available. The related findings may consequently be
subject to bias based on the indirect methods used.
Generalization of the data of this study, raised in the cardiovas-
cular field, to other medical specialties has to be handled with
caution. Nevertheless, given the diversity and quantity of cardio-
vascular science worldwide as well as the size of the cohort in
this study, our findings may be of interest to a broader audience
of scientists in different fields of medical research.
Conclusions and possible room for
improvement
High quality-research was determined by prospective study design
that was readily identified at Congress level. Average reviewer
ratings predicted frequent citation rates, indicating an effective
evaluation process at Congress level. The scientometric follow-up
revealed an unexpected disparity between predictors of publica-
tion and citation, suggesting a disadvantage of non-academic insti-
tutions and female senior authors at publication level. The
observed discrepancy between blinded peer review at Congress
level and largely single-blinded peer review at publication level indi-
cates that blinding handling editors and reviewers at publication
level may merit a closer look.
Supplementary material
Supplementary material is available at European Heart Journal online.
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